EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeitOpen Access · CC BY 4.0

Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer

Dana Taizhanova, Nurgul Serikbay iD, Pedro Henrique Fernandes do Carmo Las Casas iD, Jovana Mijucic iD, Bodaubay Roza, Dmitry Zubkov, Diana Toleubekova, Veronica Bovt, Zoubida Tazi Mezalek iD, Patrick Vandreden iD, Mohammed A Baghdadi iD, Nida Saleem und 7 weitere

International Journal of Molecular Sciences · 16.08.2026 · 27 (16) · 7302

DOI: 10.3390/ijms27167302 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.08.2026. Verfasst von Dana Taizhanova und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases, NJSC Karaganda Medical University, 100000 Karaganda, Kazakhstan. Hauptthemen laut MEDLINE: Thrombophilia, Breast Neoplasms, Uterine Cervical Neoplasms, Thrombosis. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-associated thrombosis (CAT) is a major cause of morbidity and mortality in patients with malignancy. Biomarkers of hypercoagulability and thromboinflammation may improve risk stratification and support personalised thromboprophylaxis, but evidence remains heterogeneous, particularly in cervical cancer. A systematic review was conducted according to PRISMA 2020. PubMed/MEDLINE, Scopus, Embase, and Web of Science were searched for studies published between January 2009 and March 2025 evaluating biological, molecular, genetic, and imaging biomarkers associated with hypercoagulability and thromboinflammation in women withcervical cancer. Evidence from breast cancer and broader CAT studies was incorporated to provide translational context. Owing to substantial methodological heterogeneity, findings were synthesised qualitatively. Twenty-five cervical cancer studies met eligibility criteria. D-dimer was the most extensively investigated biomarker and was consistently associated with VTE risk, although specificity was limited. Biomarkers of thrombin generation and fibrinolytic activation, including thrombin–antithrombin complexes, prothrombin fragment 1+2, and plasmin–α2-antiplasmin complex, demonstrated greater mechanistic specificity. Multimarker panels integrating coagulation, fibrinolysis, endothelial injury, platelet activation, and inflammation showed superior predictive performance compared with single biomarkers. Emerging biomarkers, including circulating tumour DNA, extracellular vesicles, and microRNAs, further supported tumour-driven thromboinflammation. SERPINE1 and F2 gene variants were associated with thrombotic risk and adverse prognosis. Current evidence supports further evaluation of integrated multimodal biomarker strategies for CAT risk assessment, but prospective, standardised, tumour-specific studies are required before biomarker-guided approaches can be implemented in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombophiliaBreast NeoplasmsUterine Cervical NeoplasmsThrombosisThromboinflammationBiomarkers, TumorHumansFemaleBiomarkersFibrin Fibrinogen Degradation Products

Stichwörter der Autor:innen

biomarkersbreast cancercancer-associated thrombosiscervical cancercoagulomeextracellular vesicleshypercoagulabilityprecision medicinethromboinflammationvenous thromboembolism

Substanzen

BiomarkersBiomarkers, Tumorfibrin fragment DFibrin Fibrinogen Degradation Products

Autor:innen und Institutionen

  • Department of Internal Diseases, NJSC Karaganda Medical University, 100000 Karaganda, Kazakhstan.
  • Multidisciplinary Hospital No. 1, 100000 Karaganda, Kazakhstan.
  • Clinic of Karaganda Medical University, 100000 Karaganda, Kazakhstan.
  • CaVITE Research Team, Consultation Thrombosis in Oncology (CoThON), Saint-Antoine Research Centre (CRSA), INSERM UMR_S_938, Saint-Antoine University Hospital, University Institute of Cancerology (UIC), Assistance Publiq…
  • Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.
  • Department of Obstetrics, Gynecology and Perinatology, NJSC Karaganda Medical University, 100000 Karaganda, Kazakhstan.

ORCID-Profile: Nurgul Serikbay, Pedro Henrique Fernandes do Carmo Las Casas, Jovana Mijucic, Zoubida Tazi Mezalek, Patrick Vandreden, Mohammed A Baghdadi, Eleftheria Elmina Lefkou, Fakiha Siddiqui, Prakasha Kempaiah, Grigoris T Gerotziafas

Zitieren

APA

Taizhanova, D., Serikbay, N., Casas, P. H. F. D. C. L., Mijucic, J., Roza, B., Zubkov, D., Toleubekova, D., Bovt, V., Tazi Mezalek, Z., Vandreden, P., Baghdadi, M. A., Saleem, N., Tafur, A., Lefkou, E. E., Siddiqui, F., Kempaiah, P., Fareed, J., Bitsadze, V., & Gerotziafas, G. T. (2026). Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer. International Journal of Molecular Sciences, 27(16), 7302. https://doi.org/10.3390/ijms27167302

Vancouver

Taizhanova D, Serikbay N, Casas PHFDCL, Mijucic J, Roza B, Zubkov D, et al. Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer. International Journal of Molecular Sciences. 2026;27(16):7302. doi:10.3390/ijms27167302

BibTeX
@article{Taizhanova2026,
  author = {Taizhanova, Dana and Serikbay, Nurgul and Casas, Pedro Henrique Fernandes do Carmo Las and Mijucic, Jovana and Roza, Bodaubay and Zubkov, Dmitry and Toleubekova, Diana and Bovt, Veronica and Tazi Mezalek, Zoubida and Vandreden, Patrick and Baghdadi, Mohammed A and Saleem, Nida and Tafur, Alfonso and Lefkou, Eleftheria Elmina and Siddiqui, Fakiha and Kempaiah, Prakasha and Fareed, Jawed and Bitsadze, Victoria and Gerotziafas, Grigoris T},
  title = {Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7302},
  doi = {10.3390/ijms27167302}
}
Kostenlos starten →